Kynam Capital Management, LP Neoleukin Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.5 - $0.72 $399 - $574	-798 Reduced 0.66%	119,966 $83,000
Q4 2022 Feb 14, 2023	BUY	$0.4 - $0.55 $158 - $217	396 Added 0.33%	120,764 $61,000
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $2,989 - $5,762	-4,333 Reduced 3.47%	120,368 $77,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $14,542 - $35,565	-15,807 Reduced 11.25%	124,701 $128,000
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $11,166 - $33,953	-6,492 Reduced 4.42%	140,508 $264,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $683,550 - $1.14 Million	147,000 New	147,000 $709,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.